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  ABSTRACT 
 
Background: Maternal mental disorders during 
pregnancy are associated with a range of adverse 
health outcomes for infants. Recent studies indi-
cate the possible mechanism of maternal mental 
health disorders associated with fetal develop-
ment through programming effect. This study 
aimed to systematically review the effect of ante-
natal mental health disorders on fetal growth. 
Subjects and Method: This was a systematic 
review. The articles were selected from Psyc-
INFO, Medline, Web of Science, Embase, and 
PubMed journal databases published from July 
to September 2018. The keywords for this review 
included maternal mental health AND fetal 
growth, postpartum depression AND fetal 
growth, maternal mental health AND fetal 
growth AND review. As many as 11 articles were 
selected for this study from 575 articles. 
Results: Maternal mental health during preg-
nancy was associated with fetal head circum-
ference growth through 2 mechanism: (1) In-
creased maternal stress response modifies neuro-
endocrine function, which included changes in 
cortisol regulation, adrenocorticotropic, adrena-
line and noradrenaline hormones levels; and (2) 
Decreased 11β-hydroxysteroid dehydrogenase 
(11β-HSD2) enzyme regulation in placenta. It 
decreased11β-HSD2 level, increased fetal gluco-
corticoids circulation, and affected on fetal head 
growth restriction. 
Conclusion: Maternal mental health during 
pregnancy is associated with fetal head circumfe-
rence growth restriction. 
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BACKGROUND 
Psychological disorders have been reported 
as a major complication of pregnancy. Post-
partum depression (PPD) is one of the main 
psychological disorders (Lewis, Austin and 
Galbally, 2016). PPD includes major and 
minor depression which affects at least 14.5% 
(one in seven women) in the first three 
months of their postpartum with a preva-
lence that rises to 59% in the post-partum 
population in large cities (Gaynes et al., 
2005). In addition, anxiety disorders during 
pregnancy have a higher prevalence than in 
the postpartum period about 50% of women 
with symptoms of PPD also experience dep-
ression or anxiety during their pregnancy 
(Bennett et al., 2004).  
Studies report that anxiety or stress du-
ring pregnancy have a prevalence of around 
13% in the second trimester and 22% in the 
first trimester. Depressive disorders include 
several diagnostic subtypes’ namely major 
depression (MDD) and dysthymia disorders 
(dysthymia) which are di-vided into chronic 
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and persistent dysthymia. Anxiety disorders 
also consist of various subtypes including 
chronic anxiety disorders that are cha-
racterized by concerns about daily life, social 
anxiety or specific phobias (American Psy-
chiatric Association, 2013). Previous studies 
have shown high levels of comorbidity 
between antenatal mental disorders that have 
the potential to cause mental disorders in 
fetal development (Howard et al., 2014).  
Mothers with poor mental health du-
ring pregnancy tend to give birth to babies 
with low preterm birth weights, and growth 
disorders (Lewis et al., 2016). Growth distur-
bance in this case is caused by adaptation re-
sults from placental and hypoxic-ischemic 
insufficiency. Symptoms that occurred clini-
cally include reduced Doppler pulsation, bio-
metric reduction in the abdominal circum-
ference (AC). Thus, as the brain grows, an 
asymmetrical growth pattern is reflected in 
the head circumference (HC)/AC ratio (Bas-
chat, 2011). The purpose of this study was to 
review systematically the effects of antenatal 
mental health disorders on fetal growth. 
 
SUBJECTS AND METHOD 
1. Study Design 
This systematic review was based on the pre-
ferred reporting items for systematic reviews 
and Meta-analyzes (PRISMA) guidelines (Li-
berati et al., 2009). The study was conducted 
from July to September 2018. A systematic 
review was carried out by searching for arti-
cles from PsycINFO, Medline, Web of Scien-
ce, Embase and Scopus. Keywords to search 
for this article include: maternal mental 
health AND fetal growth, postpartum dep-
ression AND fetal growth, maternal mental 
health AND fetal growth AND review.  
2. Inclusion and Exclusion Criteria 
Inclusion criteria for articles were cohort stu-
dies, article reviews, and clinical reviews. 
Fetal growth is measured during pregnancy 
through ultrasonography. Maternal mental 
health included one or more depressions, 
anxiety and stress measured during preg-
nancy using a validated instrument. The ex-
clusion criteria were cross-sectional, meta-
analysis, case-control, and systematic review 
study. Fetal growth that measured without 
using ultrasonography was excluded in this 
study.  
3. Data Extraction 
A total of 575 articles were collected from 
PsycINFO, Medline, Web of Science, Embase 
and Scopus databases using Mendeley prog-
ram. The articles selected using Preferred Re-
porting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) method. A total of 
11 articles were included for this study.  
 
RESULTS 
After removing duplication and applying 
exclusion criteria and examining the full text 
article carefully, finally 11 articles were 
included for further discussion. 
1. 11β-hydroxysteroid dehydrogenase 
(11β-HSD) 
11β-hydroxysteroid dehydrogenase (11β-HS-
D) is a key enzyme for glucocorticoid meta-
bolism (GC), there are two types of 11β-HSD 
which are 11β-HSD1 and 11β-HSD2 (Ni et al., 
2018). 11β-HSD1 is an enzyme that is ex-
pressed in the liver, testes, ovaries, lungs, 
and placenta. 11β-HSD1changes 11-ketoglu-
cocorticoid inert biologically (cortisone, 11-
dehydrocorticosterone) to 11-active hydroxi-
glucocorticoids (cortisol, corticosterone) 
(Thompson et al., 2004). 
In the human placenta, 11βHSD1 loca-
ted in the decidua where it guarantees the 
availability of active GCto maintain immuno-
suppressive effects that function for imp-
lantation of blastocysts and immunological 
tolerance to tissues (Quinkler et al., 2001). 
11β-HSD2 is expressed in mineralo-
corticoid target tissues, such as the kidneys, 
salivary glands, ileum, distal colon, and pla-
centa (Ni et al., 2018). In humans, 11β-HSD2 
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catalyzes inactive 11-oxo and converts corti-
sol to an inactive GC, cortisone. In the human 
placenta, 11β-HSD2 expressed selectively in 
syncytiotrophoblasts which function to block 
more than 5 ~ 10 times the maternal GC into 
the fetal blood circulation, (Achard et al., 
2006). These enzymes play a role in the pro-
cess of fetal development and will be discuss-
ed later. 
A large number of epidemiological stu-
dies showed that pregnancy complications 
cause intrauterine growth restriction (IUGR), 
low birth weight and premature birth. Among 
the complications pregnancy, there was ex-
cessive fetal exposure to GC due to psycho-
logical disorders in the form of maternal 
stress. 
Increased GC levels in intrauterine fetal 
circulation are controlled by placental gluco-
corticoids. Usually, 11β-HSD2 in the pla-
cental syncytiotrophoblast layer catalyzes the 
mother's active cortisol into inactive corti-
sone, blocking the entry of cortisol into the 
fetus (Wächter et al., 2009). However, when 
maternal GC levels increase beyond the pla-
cental capacity of 11βHSD2 for GC inacti-
vation, this pathological condition impaired 
placental function (placental insufficiency) 
and can cause excessive fetal exposure to GC 
(Das and Sysyn, 2004). Excessive intra-
uterine exposure to GC induces IUGR, hyper-
glycemia and hyperten-sion in adult children 
(Seckl and Holmes, 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. PRISMA Flow Diagram 
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2. Increased response to maternal 
stress hormones and growth dis-
orders 
Maternal psychological disorders accompa-
nied by metabolic and functional changes can 
affect the fetal development. Psychological 
disorders during pregnancy cause autonomic 
changes, maternal circadian rhythm dis-
orders, and changes in behavior that can af-
fect the mother's diet and lifestyle (Lewis et 
al., 2015). 
Such physiological changes can affect 
the availability of oxygen, glucose to the fe-
tus, interfere with placental endocrine func-
tion, induce fetal oxidative stress, and reduce 
fetal Insulin-like Growth Factor (IGF I and 
IGF II) which directly regulate fetal develop-
ment and growth (Lewis et al., 2015).  
Various mechanisms by which maternal 
mental disorders can affect fetal development 
were associated with increased maternal 
stress hormones such as cortisol, adreno-
corticotropic hormone (ACTH) and adre-
naline (Seth et al., 2015). 
Specific mechanisms which maternal 
mental disorders may affect fetal develop-
ment include: First, maternal psychological 
pressure was often (but not always) related to 
modifications in neuroendocrine function, 
because an increase in maternal stress res-
ponse caused changes in cortisol regulation, 
changes in adrenocorticotropic levels, adre-
naline, and noradrenalin (Diego et al., 2006). 
Both increased maternal glucocorticoid cir-
culation throughout pregnancy and release of 
the hormone corticotropin (CRH) in mid-
pregnancy were also associated with prenatal 
depression (Seng et al., 2010). 
A number of studies, both animal and 
human, have shown that an increase in the 
maternal hypothalamic pituitary (HPA) and 
the sympathetic nervous system caused a 
decrease in blood supply to the uterine blood 
vessels, this can reduce fetal insulin levels 
(Lewis et al., 2016). 
This mechanism can interfere with 
fetal nerve development, reduce density and 
function of brain cells. It is possible that 
these processes result not only in intrauterine 
growth restriction or preterm birth but may 
also have a long-term effect on fetal mental 
health through the fetal HPA axis (increase 
or blunt cortisol response, increased CRH, 
changes in the sympathetic nervous system 
and cardiovascular function) (Wu et al., 
2012).  
In addition, the relationship between 
maternal mental health and fetal develop-
ment that may have mechanical implications 
was the use of antidepressants by pregnant 
women who were depressed and anxiety the 
effect of using anti-depressants during preg-
nancy was also important to fetal growth (Lee 
et al., 2007). 
3. Decreased regulation of the enzyme 
11β-hydroxysteroid dehydrogenase 
(11β-HSD2) in the placenta 
The placenta has function as a temporary 
endocrine structure, which regulated the 
transfer of nutrients to the fetus and protects 
them from the effects of maternal glucocorti-
coid growth inhibitors. A decrease in 11-
HSD2 placenta would increase fetal gluco-
corticoid circulation and have an impact on 
fetal development including head circumfe-
rence, fetal HPA shaft development and fetal 
hormonal programming (Lewis et al., 2015). 
The neuroendocrine aspect of the stress 
response that can lead to stunted fetal deve-
lopment has long-term implications for sus-
ceptibility to various cognitive and emotional 
disorders, especially depression, anxiety, and 
mental health conditions. This mechanism 
explained the level of expression of 11-HSD2 
in the placenta directly affected by the cir-
culation of maternal stress hormones.  
 
DISCUSSION 
Fetal growth is a complex process governed 
by various factors including maternal and 
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fetal genetics, maternal nutrition that deter-
mines the availability of nutrients and oxygen 
for the fetus, placental vascular dysfunction, 
but maternal psychological health conditions 
are also related to the interaction of the pla-
cental system. 
Maternal mental health during preg-
nancy was associated with limiting growth in 
fetal head circumference. Through various 
mechanisms including: increased gluco-
corticoids (GC) and 11β-HSD2, changes in the 
regulation of the mother's cortisol, adreno-
corticotropic, adrenaline, noradrenaline, 
release of corticotropin hormone (CRH) in-
creased hypothalamic pituitary (HPA) and 
increased pressure on the sympathetic ner-
vous system have been studied as a cortico-
tropin hormone (CRH) the onset of placental 
insufficiency. 
This placental insufficiency caused a 
decrease in the availability of oxygen, glucose 
to the fetus, interferes with placental endo-
crine function, induces fetal oxidative stress, 
and reduced fetal insulin circulation such as 
growth factors (IGF I and IGF II) which fur-
ther disrupt fetal development and growth. 
Findings from the current review high-
light the role of maternal anxiety during 
pregnancy as a major exposure to fetal deve-
lopmental disorders. The review found con-
sistent evidence for an association between 
maternal anxiety and decreased fetal head 
growth. This finding was important because 
it showed that maternal anxiety and psycho-
logical disorders in pregnancy was not only 
have an impact on children's behavior prob-
lems. 
Anxiety and stress that can be detected 
early in pregnancy, which may certainly make 
an important difference to the fetus, both 
from physical and mental development. 
Therefore, assistance, classes of pregnant 
women, and various psychological handling 
activities during pregnancy and post preg-
nancy became important to note. 
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